Law360, New York (August 17, 2012, 4:55 PM ET) -- On Aug. 16, 2012, the U.S. Court of Appeals for the Federal Circuit decided Association for Molecular Pathology v. Myriad Genetics Inc., No. 2010-1406, on remand from the U.S. Supreme Court to consider the impact of Mayo Collaborative Services v. Prometheus Inc., 566 U.S. ___, 132 S. Ct. 1289 (2012). As explained below, the Federal Circuit’s ruling largely aligns with the same panel’s previously vacated July 29, 2011, decision.
On the threshold issue of jurisdiction, the court reaffirmed the district court’s decision to exercise declaratory judgment...
Myriad — Under The Microscope
To view the full article, take a free trial now.
